$MVIS

MVIS Q3'26 Earnings: revenue estimate is 2.00M USD

MicroVision (MVIS) will report Q3'26 earnings on October 28. Analysts expect revenue of 2.00M USD and a loss of 0.75 USD per share. The results will be released after market close.

Original reporting
Published Oct 21, 2026, 11:01 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 21, 2026, 11:07 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
MVIS Q3'26 Earnings: revenue estimate is 2.00M USD — source image
Decision brief

The 30-second read

$MVISBearishLow
01

Why it matters

The modest revenue forecast suggests limited near‑term growth, likely prompting a sell‑off in the stock.

02

Market read

The earnings preview is the primary new information for MVIS, but its small scale limits broader market impact.

03

What to watch

Potential undisclosed contracts or upcoming product launches not reflected in the estimate.

Relevance 5/10Novelty 5/10Timing: after market close on Oct 28

Background

MicroVision is a micro‑cap company developing display and projection technologies. The article provides its upcoming earnings estimate.

Company-level read

Ticker impact

$MVISBearishMedium confidence
Context

MicroVision (MVIS) will release Q3'26 earnings on Oct 28 with a revenue estimate of $2.0M and EPS of -$0.75, a new disclosure for the micro‑cap.

Expected impact

downside as investors price in low revenue and negative EPS

Evidence & confidence

The $2M revenue estimate is far below typical expectations for a listed company, suggesting limited growth and prompting a bearish reaction.

Market effects

Minimal impact on the broader AR/VR or display technology sector due to MVIS's small size.

Negligible effect on US markets; micro‑cap segment may see slight dip.

Limited global relevance; only investors tracking micro‑caps may react.

Counterpoint

If MVIS secures a strategic partnership, the low guidance could be a buying opportunity at a depressed price.

Key entities

  • MicroVision, Inc.

    NASDAQ‑listed micro‑cap providing AR/VR display solutions.

Related articles

$MVISHigh

MicroVision (MVIS) Q3 2026 Earnings Call Transcript

MicroVision (MVIS) reported Q3 2026 revenue of $2.4M, up from $0.2M in Q3 2025, with year-to-date revenue at $4.8M. The company expects full-year 2026 revenue of $10M-$15M and aims to double that in 2027. Operating cash burn is targeted at $60M for 2026 and $40M for 2027, with workforce reductions and other cost-cutting measures in place. The company is focused on nondilutive funding sources and strategic partnerships.

$MVISMed

MicroVision Reports Third Quarter 2026 Results with Record Lidar Revenue and Accelerated Path to Profitability

MICROVISION, INC. (MVIS) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 MicroVision Reports Third Quarter 2026 Results with Record Lidar Revenue and Accelerated Path to Profitability Sustained revenue growth, shipping to meet high demand, confidence in 2026 revenue guidance, implemented cost reductions ORLANDO, Fla. – October 28, 2026 –

$FULCMed

Why Did FULC, MVIS, HRTX Stocks Plunge To 52-Week Lows Today?

Fulcrum Therapeutics (FULC) fell 51% to a 52-week low of $2.9 after halting development of its lead sickle cell disease treatment due to FDA cancer risk concerns. Heron Therapeutics (HRTX) dropped 45% to $0.44 following a court ruling invalidating key patents for CINVANTI. MicroVision (MVIS) declined 32% to $0.4 after proposing a reverse stock split to meet Nasdaq requirements.

$MVISMedAI 8/10

MicroVision, Inc.: MicroVision Announces Pricing of $17.0 Million Public Offering

MicroVision (NASDAQ:MVIS) priced a public offering of 6.8 million units at $2.50 per unit, with each unit including one share and one immediately exercisable warrant to buy one share at $2.50, expiring five years after issuance. Gross proceeds are expected at about $17.0 million. Proceeds will fund general corporate purposes, including working capital and capex. Closing is expected around Aug. 17, 2026.

$MVISMedAI 8/10

MicroVision, Inc.: MicroVision Announces Launch of Proposed Public Offering

MicroVision (NASDAQ:MVIS) said it has commenced a proposed public offering of units, each unit consisting of one share of common stock (or a pre-funded warrant in lieu) and one warrant to buy one share. MicroVision will sell the shares and warrants, with final terms to be set at pricing. Net proceeds are for general corporate purposes, including working capital and capex.